Skip to content

Evaluation Conducted to Capture Patients With Diabetic Retinopathy in General Practitioners, Using SW as Medical Device

A Prospective, Comparative Multicenter Evaluation Conducted to Capture Patients With Diabetic Retinopathy in General Practitioners, Using the SW as Medical Device and the SW as MD Comparator, When Evaluating the Patient's Retinal Image

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06467903
Acronym
Retina
Enrollment
1000
Registered
2024-06-21
Start date
2024-06-07
Completion date
2024-12-15
Last updated
2024-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

A prospective, comparative multicenter evaluation conducted to capture patients with diabetic retinopathy in general practitioners, using AI medical device

Detailed description

A prospective, comparative multicenter evaluation conducted to capture patients with diabetic retinopathy in general practitioners, using the SWaMD medical device and the SWaMD comparator, when evaluating the patients retinal image

Interventions

DEVICESW as medical devices(comperator) to evaluate the retinal image of the patient's eye (to identify if the patient has DR or if the patient is healthy) .

second AI medical device to evaluate the retinal image of the patient's eye. two AI as MD will be evaluating the retinal image

Sponsors

Bonmedix Holding a.s.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Intervention model description

specific screening exhamination

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men and women aged ≥ 40 years * Signed informed consent * Confirmed type 1 or 2 diabetes mellitus

Exclusion criteria

* Ocular findings that do not allow retinal photography (significant nystagmus, corneal leukoma, dense cataract, hemophthalmus, etc.) * Patient has a condition or is in a situation that, in the opinion of the investigator, may bias the results of the study, may significantly interfere with the patient's participation in the investigation, or may result in unproducible photographs of a dilated ocular fundus * Patients with restrictions on personal freedom by administrative or legal order

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and specificity3 monthsThe sensitivity and specificity will be calculated using the evaluation of independent masked expert (ophthalmologist) as gold standard.

Countries

Czechia

Contacts

Primary ContactPavlina Kasparova Walter, MBA
pavlinakasparova@gmail.com776661512
Backup ContactJiří Tomšej, ING
tomsej@viderai.com777108402

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026